How many studies have been conducted on Dianhydrogalactitol?

BiohacksAI has indexed 126 PubMed studies on Dianhydrogalactitol, including 6 randomized controlled trials (RCTs). 33% of studies involve human subjects.

What are the main research areas for Dianhydrogalactitol?

The primary research domains for Dianhydrogalactitol are 🔬 Oncology, 🛡️ Immunity, 🫁 Liver & Detox. This is based on analysis of 126 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Dianhydrogalactitol

One of the cytotoxic dihalohexitols that alkylates and cross-links DNA via an epoxide group during all phases of the cell cycle, resulting in a disruption of DNA function and cell cycle arrest. It has antineoplastic activity and also causes bone marrow toxicity.

126+ PubMed studies analyzed · 6 RCTs · Evidence Score: 42.9

Research Domains

Dianhydrogalactitol has been studied across 10 research domains including 🔬 Oncology, 🛡️ Immunity, 🫁 Liver & Detox, 🦠 Gut & Microbiome, 😴 Sleep. The primary research focus is 🔬 Oncology with 60% of studies addressing this area.

Loading evidence profile...

This evidence profile for Dianhydrogalactitol is generated deterministically from 126 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.